Blog - The Cambridge Crystallographic Data Centre (CCDC)

The past, the present, the future

Lucy White – Fri, 28 Jun 2019 14:41:00 GMT

We are delighted to announce that today we have launched our new logo as part of our plans to refresh our visual identity.

Insights into drug-like compounds from crystal data

Seth Wiggin – Fri, 14 Jun 2019 09:00:00 GMT

As the size of the Cambridge Structural Database (CSD) has just passed one million structures, it seems an appropriate time to look at some of the applications of this ever-growing resource. Whilst the CSD is certainly useful as a central record of past data collections, perhaps the more significant benefits are the insights that can be gained from looking at this mass of data as a whole. In this blog, I’ll show some examples of what can be discovered from statistics generated from the CSD when looking at drug-like compounds. A paper written by CCDC colleagues with researchers from Pfizer and AstraZeneca (Journal of Pharmaceutical Sciences, Volume 108, Issue 5, 2019, Pages 1655-1662, https://doi.org/10.1016/j.xphs.2018.12.011) gives an in-depth statistical analysis of drug compounds in the CSD.

A million thanks

Suzanna Ward – Thu, 06 Jun 2019 08:00:00 GMT

Today marks a huge milestone in structural chemistry – the sharing of one million organic and metal-organic crystal structures, an achievement of which the entire community should be extremely proud! The creation of the Cambridge Structural Database (CSD) to share and distribute these structures is truly a team effort. Crystallographers worldwide deposit their data with us and our team of Deposition Coordinators and Scientific Editors here in Cambridge curate and enhance their structures into the database.

Blog June 2019

The past, the present, the future

Insights into drug-like compounds from crystal data

A million thanks

Search Blogs

Topics

Archive